These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29781588)

  • 21. Changes in forced vital capacity over time in systemic sclerosis: application of group-based trajectory modelling.
    Man A; Davidyock T; Ferguson LT; Ieong M; Zhang Y; Simms RW
    Rheumatology (Oxford); 2015 Aug; 54(8):1464-71. PubMed ID: 25784774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
    Arjomandi M; Zeng S; Barjaktarevic I; Barr RG; Bleecker ER; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Cooper CB; Couper DJ; Curtis JL; Dransfield MT; Han MK; Hansel NN; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Paine R; Peters SP; Rennard SI; Woodruff PG;
    Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31439683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cigarette smoking is not a risk factor for systemic sclerosis.
    Chaudhary P; Chen X; Assassi S; Gorlova O; Draeger H; Harper BE; Gonzalez E; McNearney T; Perry M; Arnett FC; Mayes MD
    Arthritis Rheum; 2011 Oct; 63(10):3098-102. PubMed ID: 21647865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Symptoms and lung function decline in a middle-aged cohort of males and females in Australia.
    Abramson MJ; Kaushik S; Benke GP; Borg BM; Smith CL; Dharmage SC; Thompson BR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1097-103. PubMed ID: 27307725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of prognostic factors for skin sclerosis and lung function in Japanese patients with early systemic sclerosis: a multicentre prospective observational study.
    Hasegawa M; Asano Y; Endo H; Fujimoto M; Goto D; Ihn H; Inoue K; Ishikawa O; Kawaguchi Y; Kuwana M; Muro Y; Ogawa F; Sasaki T; Takahashi H; Tanaka S; Takehara K; Sato S
    Rheumatology (Oxford); 2012 Jan; 51(1):129-33. PubMed ID: 22072085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
    Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
    Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross-Sectional Study.
    Lescoat A; Yelnik CM; Coiffier G; Wargny M; Lamotte C; Cazalets C; Belhomme N; Ballerie A; Hatron PY; Launay D; Perdriger A; Sobanski V; Hachulla E; Jégo P
    Arthritis Rheumatol; 2019 Jun; 71(6):983-990. PubMed ID: 30552835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Levels of Serum Serotonin Can Be Related to Skin and Pulmonary Manifestations of Systemic Sclerosis.
    Petrić M; Perković D; Božić I; Marasović Krstulović D; Martinović Kaliterna D
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208486
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of Scleroderma Clinical Trials Consortium training recommendations on modified Rodnan skin score assessment in scleroderma.
    Low AHL; Ng SA; Berrocal V; Brennan B; Chan G; Ng SC; Khanna D
    Int J Rheum Dis; 2019 Jun; 22(6):1036-1040. PubMed ID: 30838791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of serum SCUBE-1, -2 and -3 levels with clinical findings and ultrasonographic skin thickness in systemic sclerosis patients.
    Gündüz İ; Batmaz İ; Bozan T; Ekinci A; Cevik R
    Int J Rheum Dis; 2020 Apr; 23(4):526-531. PubMed ID: 31991528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of occupational pesticide exposure with accelerated longitudinal decline in lung function.
    de Jong K; Boezen HM; Kromhout H; Vermeulen R; Postma DS; Vonk JM
    Am J Epidemiol; 2014 Jun; 179(11):1323-30. PubMed ID: 24780843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and laboratory characteristics of systemic sclerosis patients with pulmonary arterial hypertension in China.
    Huang J; Li M; Tian Z; Hsieh E; Wang Q; Liu Y; Xu D; Hou Y; Zhao J; Guo X; Lai J; Hu C; Song N; Sun Q; Sun Q; Zhang F; Zhao Y; Zeng X
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-115-21. PubMed ID: 25372797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of gastroesophageal factors and worsening of forced vital capacity in systemic sclerosis.
    Zhang XJ; Bonner A; Hudson M; ; Baron M; Pope J
    J Rheumatol; 2013 Jun; 40(6):850-8. PubMed ID: 23547215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antinuclear antibody-negative systemic sclerosis.
    Salazar GA; Assassi S; Wigley F; Hummers L; Varga J; Hinchcliff M; Khanna D; Schiopu E; Phillips K; Furst DE; Steen V; Baron M; Hudson M; Taillefer SS; Pope J; Jones N; Docherty P; Khalidi NA; Robinson D; Simms RW; Silver RM; Frech TM; Fessler BJ; Molitor JA; Fritzler MJ; Segal BM; Al-Kassab F; Perry M; Yang J; Zamanian S; Reveille JD; Arnett FC; Pedroza C; Mayes MD
    Semin Arthritis Rheum; 2015 Jun; 44(6):680-6. PubMed ID: 25578738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.
    Hoffmann-Vold AM; Aaløkken TM; Lund MB; Garen T; Midtvedt Ø; Brunborg C; Gran JT; Molberg Ø
    Arthritis Rheumatol; 2015 May; 67(8):2205-12. PubMed ID: 25916462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequency of Exposure to Secondhand Smoke Outside the Home Is Associated with a Lower FEV
    Inomoto A; Yamato H; Michishita R; Jiang Y; Nishiyama S; Fukuda R; Deguchi J
    J UOEH; 2019; 41(1):15-24. PubMed ID: 30867396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study.
    Jaeger VK; Tikly M; Xu D; Siegert E; Hachulla E; Airò P; Valentini G; Matucci Cerinic M; Distler O; Cozzi F; Carreira P; Allanore Y; Müller-Ladner U; Ananieva LP; Balbir-Gurman A; Distler JHW; Czirják L; Li M; Henes J; Jimenez SA; Smith V; Damjanov N; Denton CP; DelGaldo F; Saketkoo LA; Walker UA;
    Rheumatology (Oxford); 2020 Jul; 59(7):1684-1694. PubMed ID: 31680161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
    Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
    BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.